142 (Suppl), S8S21 (2012)
TGF- signaling is a key driver of this metabolic shift, upregulating enzymes such as PHGDH, PSAT1, PSPH, and SHMT1/2 that are essential for serineglycine biosynthesis and collagen production [17, 18]
Many endocrinologists now prescribe semaglutide or tirzepatide before considering insulin therapy
Clinical trials have demonstrated that semaglutide produces reductions in hemoglobin A1c levels in patients with type 2 diabetes, typically ranging from 1.0% to 1.8%, depending on the dose and patient population
Kimura et al
Improvement in Metabolic Health : Poor metabolic health, often seen in diabetes and obesity, can exacerbate pain